Skip to main content
Livermore
Livermore
ZHEN

Xenon Pharmaceuticals Inc.

XENE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001582313

In the last 90 days, Xenon Pharmaceuticals Inc. insiders filed 2 open-market purchases and 2 sales; 315 institutions reported holding it in 13F filings for Q2 2026, worth $6.10B in total; Duquesne Family Office is the only superinvestor holding it.

Q4 2024 vs. Q3 2024

How the institutions holding Xenon Pharmaceuticals Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of XENE: Q3 2024 compared with Q4 2024
MeasureQ3 2024Of which not filed for Q4 2024Q4 2024Change
Holders2032209+8
Shares74.9M26.2K76.3M+1.44M (+1.9%)
Value$2.95B$1.03M$2.99B+$42.4M (+1.4%)

2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (29)

Institutions that held Xenon Pharmaceuticals Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to XENE in Q4 2024
InstitutionSharesValue% of portfolio
Boxer Capital Management, LLC600,000$23.5M2.00%
StemPoint Capital LP375,845$14.7M3.70%
Saturn V Capital Management LLC322,470$12.6M4.95%
Great Point Partners LLC245,272$9.61M4.53%
Deep Track Capital, LP169,132$6.63M0.25%
Eversept Partners, LP155,540$6.10M0.63%
Neuberger Berman Group LLC92,961$3.64M0.00%
BIT Capital GmbH53,928$2.11M0.19%
Sphera Funds Management Ltd.52,097$2.04M0.38%
Woodline Partners LP39,938$1.57M0.01%
Allostery Investments LP30,000$1.18M2.31%
Raymond James Financial Inc20,331$797.1K0.00%
J. Safra Sarasin Holding AG17,786$697.2K0.01%
KLP Kapitalforvaltning AS12,800$501.8K0.00%
Jane Street Group, LLC11,138$436.6K0.00%
Verition Fund Management LLC8,297$325.2K0.00%
Aquatic Capital Management LLC8,260$323.8K0.01%
XTX Topco Ltd8,054$315.7K0.03%
NEOS Investment Management LLC6,111$239.6K0.01%
Tema ETFs LLC6,111$239.6K0.10%
Vident Advisory, LLC5,413$212.2K0.00%
Magnetar Financial LLC5,363$210.2K0.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC2,569$100.7K0.00%
Quarry LP2,000$78.4K0.02%
GF Fund Management Co. Ltd.1,601$62.8K0.00%
Spire Wealth Management200$7.84K0.00%
Amundi89$3.52K0.00%
Quadrant Capital Group LLC66$2.59K0.00%
Hexagon Capital Partners LLC6$2350.00%

Sold out (21)

Institutions that held Xenon Pharmaceuticals Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of XENE in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Boxer Capital, LLC600,000$23.6M
Point72 Asset Management, L.P.383,290$15.1M
Jefferies Financial Group Inc.66,500$2.62M
Jump Financial, LLC45,000$1.77M
Gsa Capital Partners LLP37,308$1.47M
Y-Intercept (Hong Kong) Ltd24,557$966.8K
Vestcor Inc8,300$327.0K
Aigen Investment Management, LP7,370$290.2K
Campbell & CO Investment Adviser LLC7,339$288.9K
Qube Research & Technologies Ltd6,938$273.1K
Engineers Gate Manager LP5,581$219.7K
Oppenheimer Asset Management Inc.5,306$208.9K
nVerses Capital, LLC2,600$102.4K
Accent Capital Management, LLC400$15.7K
Group One Trading, L.P.104$4.09K
Clear Street Markets LLC90$4.00K
Danske Bank A/S100$3.94K
Wolff Wiese Magana LLC61$2.40K
Point72 (DIFC) Ltd34$1.34K
Park Place Capital Corp18$709
SRS Capital Advisors, Inc.3$119

Not filed for Q4 2024 yet (2)

Institutions that held Xenon Pharmaceuticals Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding XENE in Q3 2024 that haven't filed for Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Chartwell Investment Partners, LLC18,213$717.0K
PEAK6 Investments LLC8,000$315.0K